The mitochondrial dynamics in cancer and immune-surveillance

Seminars in Cancer Biology

Volumn 47, Issue , 2017, Pages 29-42

  Simula, Luca ^a,b   Nazio, Francesca ^b   Campello, Silvia ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Apoptosis; Cancer; Cell migration; Immune surveillance; Mitochondrial dynamics

Indexed keywords

CARDIOLIPIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOCHONDRIAL DNA; MITOFUSIN 1; MITOFUSIN 2; PARKIN; PROTEIN P53; VASCULOTROPIN; REACTIVE OXYGEN METABOLITE;

ADAPTIVE IMMUNITY; ANEUPLOIDY; APOPTOSIS; CELL CYCLE PROGRESSION; CELL DEATH; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HUMAN; HYDROLYSIS; IMMUNOSURVEILLANCE; MALIGNANT NEOPLASM; MEMBRANE POTENTIAL; MITOCHONDRIAL DYNAMICS; MITOPHAGY; MOLECULAR DOCKING; NERVE CELL PLASTICITY; NEUROMODULATION; NITROSYLATION; OLIGOMERIZATION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; REVIEW; SUMOYLATION; SURVIVAL RATE; TUMOR MICROENVIRONMENT; UBIQUITINATION; ANIMAL; CYTOLOGY; DRUG EFFECT; ENERGY METABOLISM; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; NEOPLASM;

ANIMALS; APOPTOSIS; ENERGY METABOLISM; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC SURVEILLANCE; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MOLECULAR TARGETED THERAPY; NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 85021747521     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2017.06.007     Document Type: Review

References (218)

1. Detmer, S.A., Chan, D.C., Functions and dysfunctions of mitochondrial dynamics. Nature Reviews Molecular Cell Biology, 2007, Nature Publishing Group, 870–879.
2. Santel, A., Frank, S., Gaume, B., Herrler, M., Youle, R.J., Fuller, M.T., Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J. Cell Sci. 116 (2003), 2763–2774.
3. Eura, Y., Ishihara, N., Yokota, S., Mihara, K., Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J. Biochem. 134 (2003), 333–344.
4. Qi, Y., Yan, L., Yu, C., Guo, X., Zhou, X., Hu, X., et al. Structures of human mitofusin 1 provide insight into mitochondrial tethering. J. Cell Biol. 215 (2016), 621–629.
5. Pich, S., Bach, D., Briones, P., Liesa, M., Camps, M., Testar, X., et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14 (2005), 1405–1415.
6. Ramos, E.S., Larsson, N.-G.r., Mourier, A., Bioenergetic roles of mitochondrial fusion. Biochim. Biophys. Acta (BBA)-Bioenerg. 1857 (2016), 1277–1283.
7. de Brito, O.M., Scorrano, L., Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456:7222 (2008), 605–610.
8. Cipolat, S., de Brito, O.M., Dal Zilio, B., Scorrano, L., OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15927–15932.
9. Anand, R., Wai, T., Baker, M.J., Kladt, N., Schauss, A.C., Rugarli, E., et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J. Cell Biol. 204 (2014), 919–929.
10. Paumard, P., Vaillier, J., Coulary, B., Schaeffer, J., Soubannier, V., Mueller, D.M., et al. The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J. 21 (2002), 221–230.
11. Kozjak-Pavlovic, V., The MICOS complex of human mitochondria. Cell Tissue Res. 367 (2017), 83–93.
12. Frezza, C., Cipolat, S., de Brito, O.M., Micaroni, M., Beznoussenko, G.V., Rudka, T., et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126 (2006), 177–189.
13. Varanita, T., Soriano, M.E., Romanello, V., Zaglia, T., Quintana-Cabrera, R.n., Semenzato, M., et al. The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab. 21 (2015), 834–844.
14. Alavi, M.V., Fuhrmann, N., Dominant optic atrophy OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol. Neurodegener., 8(1), 2013, p1.
15. Chen, H., Vermulst, M., Wang, Y.E., Chomyn, A., Prolla, T.A., McCaffery, J.M., et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141 (2010), 280–289.
16. Feely, S., Laura, M., Siskind, C., Sottile, S., Davis, M., Gibbons, V., et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 76 (2011), 1690–1696.
17. Ranieri, M., Del Bo, R., Bordoni, A., Ronchi, D., Colombo, I., Riboldi, G., et al. Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian families. J. Neurol. Sci. 315 (2012), 146–149.
18. Gal, A., Balicza, P., Weaver, D., Naghdi, S., Joseph, S.K., Várnai, P., et al. MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans. EMBO Mol. Med., 2017, e201607058.
19. Twig, G., Shirihai, O.S., The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal. 14:10 (2011), 1939–1951.
20. Jheng, H.-F., Tsai, P.-J., Guo, S.-M., Kuo, L.-H., Chang, C.-S., Su, I.-J., et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol. Cell. Biol. 32 (2012), 309–319.
21. Mitra, K., Mitochondrial fission-fusion as an emerging key regulator of cell proliferation and differentiation. Bioessays 35:11 (2013), 955–964.
22. Qian, W., Wang, J., Roginskaya, V., McDermott, L.A., Edwards, R.P., Stolz, D.B., et al. Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells. Oncotarget, 5, 2014, 4180.
23. Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., Mihara, K., Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282 (2007), 11521–11529.
24. Youle, R.J., Karbowski, M., Mitochondrial fission in apoptosis. Nat. Rev. Mol. Cell Biol. 6:8 (2005), 657–663.
25. Wasiak, S., Zunino, R., McBride, H.M., Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J. Cell Biol. 177:3 (2007), 439–450.
26. Otera, H., Ishihara, N., Mihara, K., New insights into the function and regulation of mitochondrial fission. Biochim. Biophys. Acta (BBA)—Mol. Cell Res. 1833:5 (2013), 1256–1268.
27. Friedman, J.R., Lackner, L.L., West, M., DiBenedetto, J.R., Nunnari, J., Voeltz, G.K., ER tubules mark sites of mitochondrial division. Science 334 (2011), 358–362.
28. Li, S., Xu, S., Roelofs, B.A., Boyman, L., Lederer, W.J., Sesaki, H., et al. Transient assembly of F-actin on the outer mitochondrial membrane contributes to mitochondrial fission. J. Cell Biol. 208 (2015), 109–123.
29. Shaw, J.M., Nunnari, J., Mitochondrial dynamics and division in budding yeast. Trends Cell Biol. 12:4 (2002), 178–184.
30. Smirnova, E., Griparic, L., Shurland, D.-L., Van Der Bliek, A.M., Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 12 (2001), 2245–2256.
31. Ingerman, E., Perkins, E.M., Marino, M., Mears, J.A., McCaffery, J.M., Hinshaw, J.E., et al. Dnm1 forms spirals that are structurally tailored to fit mitochondria. J. Cell Biol. 170 (2005), 1021–1027.
32. Ishihara, N., Nomura, M., Jofuku, A., Kato, H., Suzuki, S.O., Masuda, K., et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat. Cell Biol. 11 (2009), 958–966.
33. James, D.I., Parone, P.A., Mattenberger, Y., Martinou, J.-C., hFis1, a novel component of the mammalian mitochondrial fission machinery. J. Biol. Chem. 278 (2003), 36373–36379.
34. Otera, H., Mihara, K., Discovery of the membrane receptor for mitochondrial fission GTPase Drp1. Small GTPases 3 (2011), 167–172.
35. Otera, H., Wang, C., Cleland, M.M., Setoguchi, K., Yokota, S., Youle, R.J., et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191 (2010), 1141–1158.
36. Gandre-Babbe, S., van der Bliek, A.M., The novel tail-anchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. Mol. Biol. Cell 19:6 (2008), 2402–2412.
37. Palmer, C.S., Osellame, L.D., Laine, D., Koutsopoulos, O.S., Frazier, A.E., Ryan, M.T., MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep. 12 (2011), 565–573.
38. Wang, X., Yan, M.H., Fujioka, H., Liu, J., Wilson-Delfosse, A., Chen, S.G., et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet. 21 (2012), 1931–1944.
39. Niu, J., Yu, M., Wang, C., Xu, Z., Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein. J. Neurochem. 122 (2012), 650–658.
40. Alto, N.M., Soderling, J., Scott, J.D., Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J. Cell Biol. 158:4 (2002), 659–668.
41. Harada, H., Becknell, B., Wilm, M., Mann, M., Huang, L.J.-s., Taylor, S.S., et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3 (1999), 413–422.
42. Lee, J.E., Westrate, L.M., Wu, H., Page, C., Voeltz, G.K., Multiple dynamin family members collaborate to drive mitochondrial division. Nature 540 (2016), 139–143.
43. Li, H., Ruan, Y., Zhang, K., Jian, F., Hu, C., Miao, L., et al. Mic60/Mitofilin determines MICOS assembly essential for mitochondrial dynamics and mtDNA nucleoid organization. Cell Death Differ. 23 (2016), 380–392.
44. Ott, C., Dorsch, E., Fraunholz, M., Straub, S., Kozjak-Pavlovic, V., Detailed analysis of the human mitochondrial contact site complex indicate a hierarchy of subunits. PLoS One, 10, 2015, e0120213.
45. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
46. Karbowski, M., Lee, Y.-J., Gaume, B., Jeong, S.-Y., Frank, S., Nechushtan, A., et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159 (2002), 931–938.
47. Wang, P., Wang, P., Liu, B., Zhao, J., Pang, Q., Agrawal, S.G., et al. Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis. Oncotarget, 6, 2015, 22598.
48. Montessuit, S., Somasekharan, S.P., Terrones, O., Lucken-Ardjomande, S., Herzig, S.b., Schwarzenbacher, R., et al. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell 142 (2010), 889–901.
49. Karbowski, M., Norris, K.L., Cleland, M.M., Jeong, S.-Y., Youle, R.J., Role of Bax and Bak in mitochondrial morphogenesis. Nature 443 (2006), 658–662.
50. Li, H., Chen, Y., Jones, A.F., Sanger, R.H., Collis, L.P., Flannery, R., et al. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 2169–2174.
51. Renault, T.T., Floros, K.V., Elkholi, R., Corrigan, K.-A., Kushnareva, Y., Wieder, S.Y., et al. Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis. Mol. Cell 57 (2015), 69–82.
52. Yamaguchi, R., Lartigue, L., Perkins, G., Scott, R.T., Dixit, A., Kushnareva, Y., et al. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization. Mol. Cell 31 (2008), 557–569.
53. Merkwirth, C., Dargazanli, S., Tatsuta, T., Geimer, S., Lower, B., Wunderlich, F.T., et al. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes. Dev. 22 (2008), 476–488.
54. Pyakurel, A., Savoia, C., Hess, D., Scorrano, L., Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis. Mol. Cell 58 (2015), 244–254.
55. Inoue-Yamauchi, A., Oda, H., Depletion of mitochondrial fission factor DRP1 causes increased apoptosis in human colon cancer cells. Biochem. Biophys. Res. Commun. 421:1 (2012), 81–85.
56. Chiche, J., Rouleau, M., Gounon, P., Brahimi-Horn, M.C., Pouysségur, J., Mazure, N.M., Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J. Cell. Physiol. 222 (2010), 648–657.
57. Chiang, Y.-Y., Chen, S.-L., Hsiao, Y.-T., Huang, C.-H., Lin, T.-Y., Chiang, I.-P., et al. Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas. Mod. Pathol. 22 (2009), 1139–1150.
58. Fan, S., Liu, B., Sun, L., Lv, X.-b., Lin, Z., Chen, W., et al. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis. Oncotarget, 6, 2015, 14885.
59. Santin, G., Piccolini, V.M., Barni, S., Veneroni, P., Giansanti, V., Dal Bo, V., et al. Mitochondrial fusion: a mechanism of cisplatin-induced resistance in neuroblastoma cells?. Neurotoxicology 34 (2013), 51–60.
60. Benetatos, L., Hatzimichael, E., Londin, E., Vartholomatos, G., Loher, P., Rigoutsos, I., et al. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell. Mol. Life Sci. 70 (2013), 795–814.
61. Dutta, P., Haller, E., Sharp, A., Nanjundan, M., MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes. BMC Cancer, 16, 2016, 33.
62. Magi, B., Ettorre, A., Liberatori, S., Bini, L., Andreassi, M., Frosali, S., et al. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death Differ. 11 (2004), 842–852.
63. An, J., Shi, J., He, Q., Lui, K., Liu, Y., Huang, Y., et al. CHCM1/CHCHD6, novel mitochondrial protein linked to regulation of mitofilin and mitochondrial cristae morphology. J. Biol. Chem. 287 (2012), 7411–7426.
64. Faccenda, D., Nakamura, J., Gorini, G., Dhoot, G.K., Piacentini, M., Yoshida, M., et al. Control of mitochondrial remodeling by the ATPase inhibitory factor 1 unveils a pro-survival relay via OPA1. Cell Rep. 18 (2017), 1869–1883.
65. Tanwar, D.K., Parker, D.J., Gupta, P., Spurlock, B., Alvarez, R.D., Basu, M.K., et al. Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients. Oncotarget 7:37 (2016), 60021–60037.
66. Zhan, L., Cao, H., Wang, G., Lyu, Y., Sun, X., An, J., et al. Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-kB pathways in hepatocellular carcinoma. Oncotarget 7:40 (2016), 65001–65011.
67. Rehman, J., Zhang, H.J., Toth, P.T., Zhang, Y., Marsboom, G., Hong, Z., et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 26 (2012), 2175–2186.
68. Sievers, C., Billig, G., Gottschalk, K., Rudel, T., Prohibitins are required for cancer cell proliferation and adhesion. PLoS One, 5, 2010, e12735.
69. Campello, S., Lacalle, R.A., Bettella, M., Manes, S., Scorrano, L., Viola, A., Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J. Exp. Med. 203 (2006), 2879–2886.
70. Da Silva, A.F., Valacca, C., Rios, E., Pòpulo, H., Soares, P., Sobrinho-Simones, M., et al. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. PLoS One, 10, 2015, e0122308.
71. Zhao, J., Zhang, J., Yu, M., Xie, Y., Huang, Y., Wolff, D.W., et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32 (2013), 4814–4824.
72. Che, T.-F., Lin, C.-W., Wu, Y.-Y., Chen, Y.-J., Han, C.-L., Chang, Y.-l., et al. Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC. Oncotarget, 6, 2015, 37349.
73. Desai, S.P., Bhatia, S.N., Toner, M., Irimia, D., Mitochondrial localization and the persistent migration of epithelial cancer cells. Biophys. J. 104 (2013), 2077–2088.
74. Wan, Y.-Y., Zhang, J.-F., Yang, Z.-J., Cassidy-Stone ng, L.-P., Wei, Y.F., Lai, Q.-N., et al. Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells. Oncol. Rep. 32 (2014), 619–626.
75. Han, X.-J., Yang, Z.-J., Jiang, L.-P., Wei, Y.-F., Liao, M.-F., Qian, Y., et al. Mitochondrial dynamics regulates hypoxia-induced migration and antineoplastic activity of cisplatin in breast cancer cells. Int. J. Oncol. 46 (2015), 691–700.
76. Caino, M.C., Seo, J.H., Aguinaldo, A., Wait, E., Bryant, K.G., Kossenkov, A.V., et al. A neuronal network of mitochondrial dynamics regulates metastasis. Nat. Commun., 7, 2016.
77. Jung, J.-U., Ravi, S., Lee, D.W., McFadden, K., Kamradt, M.L., Toussaint, L.G., et al. NIK/MAP3K14 regulates mitochondrial dynamics and trafficking to promote cell invasion. Curr. Biol. 26 (2016), 3288–3302.
78. Wang, L., Yoon, Y., Mitochondrial fission is necessary for vascular smooth muscle cell migration (761.1). FASEB J., 28, 2014.
79. Caino, M.C., Ghosh, J.C., Chae, Y.C., Vaira, V., Rivadeneira, D.B., Faversani, A., et al. PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 8638–8643.
80. Rossignol, R., Gilkerson, R., Aggeler, R., Yamagata, K., Remington, S.J., Capaldi, R.A., Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64 (2004), 985–993.
81. Chen, H., Chomyn, A., Chan, D.C., Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280:28 (2005), 26185–26192.
82. Loiseau, D., Chevrollier, A., Verny, C., Guillet, V., Gueguen, N.g., Pou De Crescenzo, M.A., et al. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann. Neurol. 61 (2007), 315–323.
83. Picard, M., Shirihai, O.S., Gentil, B.J., Burelle, Y., Mitochondrial morphology transitions and functions: implications for retrograde signaling?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304 (2013), R393–R406.
84. Patten, D.A., Wong, J., Khacho, M., Soubannier, V., Mailloux, R.J., Pilon-Larose, K., et al. OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand. EMBO J., 2014, e201488349.
85. Pich, S., Bach, D., Briones, P., Liesa, M., Camps, M., Testar, X., et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14 (2005), 1405–1415.
86. Parone, P.A., Da Cruz, S., Tondera, D., Mattenberger, Y., James, D.I., Maechler, P., et al. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS One, 3, 2008, e3257.
87. Prieto, J., Leòn, M., Ponsoda, X., Sendra, R.n., Bort, R., Ferrer-Lorente, R., et al. Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming. Nat. Commun., 7, 2016.
88. Rambold, A.S., Kostelecky, B., Elia, N., Lippincott-Schwartz, J., Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10190–10195.
89. Lee, J.-Y., Kapur, M., Li, M., Choi, M.-C., Choi, S., Kim, H.-J., et al. MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria. J. Cell Sci. 127 (2014), 4954–4963.
90. Dietrich, M.O., Liu, Z.-W., Horvath, T.L., Mitochondrial dynamics controlled by mitofusins regulate Agrp neuronal activity and diet-induced obesity. Cell 155 (2013), 188–199.
91. Warburg, O., On the origin of cancer cells. Science 123:3191 (1956), 309–314.
92. Wallace, D., Mitochondria and cancer: Warburg addressed. Cold Spring Harbor Symposia on Quantitative Biology, 2005, Cold Spring Harbor Laboratory Press.
93. Maddalena, F., Lettini, G., Gallicchio, R., Sisinni, L., Simeon, V., Nardelli, A., et al. Evaluation of glucose uptake in normal and cancer cell lines by positron emission tomography. Mol. Imaging, 14, 2015 7290.2015.00021.
94. Koukourakis, M.I., Giatromanolaki, A., Harris, A.L., Sivridis, E., Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 66 (2006), 632–637.
95. Sciacovelli, M., Gonzalves, E., Johnson, T.I., Zecchini, V.R., da Costa, A.S.H., Gaude, E., et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537 (2016), 544–547.
96. Sciacovelli, M., Frezza, C., Fumarate drives EMT in renal cancer. Cell Death Differ. 24:1 (2016), 1–2.
97. Hervouet, E., Demont, J., Pecina, P., Vojtìskova, A., Houstek, J., Simonnet, H.l.n., et al. A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis. Carcinogenesis 26 (2005), 531–539.
98. Schulz, T.J., Thierbach, R., Voigt, A., Drewes, G., Mietzner, B., Steinberg, P., et al. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth Otto Warburg Revisited. J. Biol. Chem. 281 (2006), 977–981.
99. Plecità-Hlavatà, L., Lessard, M., Santorovà, J., Bewersdorf, J., Jezek, P., Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochondrial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy. Biochim. Biophys. Acta (BBA)—Bioenerg. 1777 (2008), 834–846.
100. Hagenbuchner, J., Kuznetsov, A., Obexer, P., Ausserlechner, M., BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. Oncogene 32 (2013), 4748–4757.
101. Konstantakou, E.G., Voutsinas, G.E., Velentzas, A.D., Basogianni, A.-S., Paronis, E., Balafas, E., et al. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants. Mol. Cancer, 14, 2015, 135.
102. Dier, U., Shin, D.-H., Hemachandra, L.M.P., Uusitalo, L.M., Hempel, N., Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line. PLoS One, 9, 2014, e98479.
103. Van Gisbergen, M., Voets, A., Starmans, M., de Coo, I., Yadak, R., Hoffmann, R., et al. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat. Res. 764 (2015), 16–30.
104. Reznik, E., Miller, M.L., Senbabaoglu, Y., Riaz, N., Sarungbam, J., Tickoo, S.K., et al. Mitochondrial DNA copy number variation across human cancers. eLife, 5, 2016, e10769.
105. Parone, P.A., Da Cruz, S., Tondera, D., Mattenberger, Y., James, D.I., Maechler, P., et al. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS One, 3, 2008, e3257.
106. Schieber, M., Chandel, N.S., ROS function in redox signaling and oxidative stress. Curr. Biol. 24 (2014), R453–R462.
107. Birben, E., Sahiner, U.M., Sackesen, C., Erzurum, S., Kalayci, O., Oxidative stress and antioxidant defense. World Allergy Organ. J., 5, 2012, 9.
108. Kobashigawa, S., Suzuki, K., Yamashita, S., Ionizing radiation accelerates Drp1-dependent mitochondrial fission, which involves delayed mitochondrial reactive oxygen species production in normal human fibroblast-like cells. Biochem. Biophys. Res. Commun. 414 (2011), 795–800.
109. Munoz, J.P., Ivanova, S.k., Sanchez-Wandelmer, J., Martinez-Cristòbal, P., Noguera, E., Sancho, A., et al. Mfn2 modulates the UPR and mitochondrial function via repression of PERK. EMBO J. 32 (2013), 2348–2361.
110. Willems, P.H., Rossignol, R., Dieteren, C.E., Murphy, M.P., Koopman, W.J., Redox homeostasis and mitochondrial dynamics. Cell Metab. 22 (2015), 207–218.
111. Pletjushkina, O.Y., Lyamzaev, K., Popova, E., Nepryakhina, O., Ivanova, O.Y., Domnina, L., et al. Effect of oxidative stress on dynamics of mitochondrial reticulum. Biochim. Biophys. Acta (BBA)—Bioenerg. 1757 (2006), 518–524.
112. Liou, G.-Y., Storz, P., Reactive oxygen species in cancer. Free Radic. Res. 44 (2010), 479–496.
113. Chatterjee, A., Mambo, E., Sidransky, D., Mitochondrial DNA mutations in human cancer. Oncogene 25:34 (2006), 4663–4674 x.
114. DeNicola, G.M., Karreth, F.A., Humpton, T.J., Gopinathan, A., Wei, C., Frese, K., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475 (2011), 106–109.
115. Piskounova, E., Agathocleous, M., Murphy, M.M., Hu, Z., Huddlestun, S.E., Zhao, Z., et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527:7577 (2015), 186–191.
116. Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., et al. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 2002–2007.
117. Xia, C., Meng, Q., Liu, L.-Z., Rojanasakul, Y., Wang, X.-R., Jiang, B.-H., Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 67 (2007), 10823–10830.
118. Kim, Y.-W., Byzova, T.V., Oxidative stress in angiogenesis and vascular disease. Blood 123 (2014), 625–631.
119. Jung, S.-N., Yang, W.K., Kim, J., Kim, H.S., Kim, E.J., Yun, H., et al. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29 (2008), 713–721.
120. Nishida, N., Yano, H., Nishida, T., Kamura, T., Kojiro, M., Angiogenesis in cancer. Vasc. Health Risk Manage., 2, 2006, 213.
121. Kim, J.-w., Tchernyshyov, I., Semenza, G.L., Dang, C.V., HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3 (2006), 177–185.
122. Huang, D., Li, T., Li, X., Zhang, L., Sun, L., He, X., et al. HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep. 8 (2014), 1930–1942.
123. Semenza, G.L., Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype. EMBO J., 2016, e201695204.
124. Twig, G., Elorza, A., Molina, A.J., Mohamed, H., Wikstrom, J.D., Walzer, G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27 (2008), 433–446.
125. Greene, A.W., Grenier, K., Aguileta, M.A., Muise, S., Farazifard, R., Haque, M.E., et al. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 13 (2012), 378–385.
126. Kane, L.A., Lazarou, M., Fogel, A.I., Li, Y., Yamano, K., Sarraf, S.A., et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol., 2014, 10.1083/jcb.201402104.
127. Lazarou, M., Sliter, D.A., Kane, L.A., Sarraf, S.A., Wang, C., Burman, J.L., et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524 (2015), 309–314.
128. Strappazzon, F., Nazio, F., Corrado, M., Cianfanelli, V., Romagnoli, A., Fimia, G.M., et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ. 22 (2015), 419–432.
129. Wu, W., Tian, W., Hu, Z., Chen, G., Huang, L., Li, W., et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep., 2014, e201438501.
130. Chu, C.T., Ji, J., Dagda, R.K., Jiang, J.F., Tyurina, Y.Y., Kapralov, A.A., et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat. Cell Biol. 15 (2013), 1197–1205.
131. Liu, L., Sakakibara, K., Chen, Q., Okamoto, K., Receptor-mediated mitophagy in yeast and mammalian systems. Cell Res. 24 (2014), 787–795.
132. Zhang, J., Ney, P.A., Role of BNIP3 and NIX in cell death autophagy, and mitophagy. Cell Death Differ. 16 (2009), 939–946.
133. Pickrell, A.M., Youle, R.J., The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85 (2015), 257–273.
134. Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y.L., Selkoe, D., et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147 (2011), 893–906.
135. Toyama, E.Q., Herzig, S.b., Courchet, J., Lewis, T.L., Losòn, O.C., Hellberg, K., et al. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351 (2016), 275–281.
136. Bin-Umer, M.A., McLaughlin, J.E., Butterly, M.S., McCormick, S., Tumer, N.E., Elimination of damaged mitochondria through mitophagy reduces mitochondrial oxidative stress and increases tolerance to trichothecenes. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 11798–11803.
137. Kurihara, Y., Kanki, T., Aoki, Y., Hirota, Y., Saigusa, T., Uchiumi, T., et al. Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J. Biol. Chem. 287 (2012), 3265–3272.
138. Wei, X., Qi, Y., Zhang, X., Qiu, Q., Gu, X., Tao, C., et al. Cadmium induces mitophagy through ROS-mediated PINK1/Parkin pathway. Toxicol. Mech. Methods 24 (2014), 504–511.
139. Joselin, A.P., Hewitt, S.J., Callaghan, S.M., Kim, R.H., Chung, Y.-H., Mak, T.W., et al. ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. Hum. Mol. Genet., 2012 dds325.
140. Matsuda, S., Nakanishi, A., Minami, A., Wada, Y., Kitagishi, Y., Functions and characteristics of PINK1 and Parkin in cancer. Front. Biosci. (Landmark Edition) 20 (2014), 491–501.
141. Pugh, T.J., Morozova, O., Attiyeh, E.F., Asgharzadeh, S., Wei, J.S., Auclair, D., et al. The genetic landscape of high-risk neuroblastoma. Nat. Genet. 45 (2013), 279–284.
142. White, E., The role for autophagy in cancer. J. Clin. Invest. 125 (2015), 42–46.
143. Cianfanelli, V., Fuoco, C., Lorente, M., Salazar, M., Quondamatteo, F., Gherardini, P.F., et al. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat. Cell Biol. 17 (2015), 20–30.
144. Huang, Q., Zhan, L., Cao, H., Li, J., Lyu, Y., Guo, X., et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy, 2016, 1–16.
145. Guo, J.Y., Chen, H.-Y., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes. Dev. 25 (2011), 460–470.
146. Senft, D., Ze'ev, A.R., Regulators of mitochondrial dynamics in cancer. Curr. Opin. Cell Biol. 39 (2016), 43–52.
147. Kashatus, J.A., Nascimento, A., Myers, L.J., Sher, A., Byrne, F.L., Hoehn, K.L., et al. Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. Mol. Cell 57 (2015), 537–551.
148. Serasinghe, M.N., Wieder, S.Y., Renault, T.T., Elkholi, R., Asciolla, J.J., Yao, J.L., et al. Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors. Mol. Cell 57 (2015), 521–536.
149. Wan, Y.-Y., Zhang, J.-F., Yang, Z.-J., Jiang, L.-P., Wei, Y.F., Lai, Q.-N., et al. Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells. Oncol. Rep. 32 (2014), 619–626.
150. Zhang, G.-E., Jin, H.-L., Lin, X.-K., Chen, C., Liu, X.-S., Zhang, Q., et al. Anti-tumor effects of Mfn2 in gastric cancer. Int. J. Mol. Sci. 14 (2013), 13005–13021.
151. Wang, W., Xie, Q., Zhou, X., Yao, J., Zhu, X., Huang, P., et al. Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. Cancer Lett. 358 (2015), 47–58.
152. Li, X., Wang, F., Wu, Z., Lin, J., Lan, W., Lin, J., MicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cells. Neoplasma 61 (2013), 265–273.
153. Poutèn, F., Jirstrom, K., Uhlen, M., The human protein atlas—a tool for pathology. J. Pathol. 216:4 (2008), 387–393.
154. Sehrawat, A., Croix, C.S., Baty, C.J., Watkins, S., Tailor, D., Singh, R.P., et al. Inhibition of mitochondrial fusion is an early and critical event in breast cancer cell apoptosis by dietary chemopreventative benzyl isothiocyanate. Mitochondrion 30 (2016), 67–77.
155. Kubohara, Y., Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent. Eur. J. Pharmacol. 381:1 (1999), 57–62.
156. Dubois, A., Ginet, C., Furstoss, N., Belaid, A., Hamouda, M.A., El Manaa, W., et al. Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death. Oncotarget 7:18 (2016), 26120–26136.
157. Jia, Y., Zhou, L., Tian, C., Shi, Y., Wang, C., Tong, Z., Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death. OncoTargets Ther., 8, 2015, 3371.
158. Cassidy-Stone, A., Chipuk, J.E., Ingerman, E., Song, C., Yoo, C., Kuwana, T., et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell 14 (2008), 193–204.
159. Wang, J., Li, J., Santana-Santos, L., Shuda, M., Sobol, R.W., Van Houten, B., et al. A novel strategy for targeted killing of tumor cells: induction of multipolar acentrosomal mitotic spindles with a quinazolinone derivative mdivi-1. Mol. Oncol. 9 (2015), 488–502.
160. Rosdah, A.A., Holien, J.K., Delbridge, L., Dusting, G.J., Lim, S.Y., Mitochondrial fission—a drug target for cytoprotection or cytodestruction?. Pharmacol. Res. Perspect., 4, 2016.
161. Xie, Q., Wu, Q., Horbinski, C.M., Flavahan, W.A., Yang, K., Zhou, W., et al. Mitochondrial control by DRP1 in brain tumor initiating cells. Nat. Neurosci. 18 (2015), 501–510.
162. Akita, M., Suzuki-Karasaki, M., Fujiwara, K., Nakagawa, C., Soma, M., Yoshida, Y., et al. Mitochondrial division inhibitor-1 induces mitochondrial hyperfusion and sensitizes human cancer cells to TRAIL-induced apoptosis. Int. J. Oncol. 45 (2014), 1901–1912.
163. Wang, J., Hansen, K., Edwards, R., Van Houten, B., Qian, W., Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells. Biochem. Biophys. Res. Commun. 456 (2015), 7–12.
164. Qian, W., Wang, J., Roginskaya, V., McDermott, L.A., Edwards, R.P., Stolz, D.B., et al. Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells. Oncotarget, 5, 2014, 4180.
165. Han, X.-J., Yang, Z.-J., Jiang, L.-P., Wei, Y.-F., Liao, M.-F., Qian, Y., et al. Mitochondrial dynamics regulates hypoxia-induced migration and antineoplastic activity of cisplatin in breast cancer cells. Int. J. Oncol. 46 (2015), 691–700.
166. Kushnareva, Y., Andreyev, A.Y., Kuwana, T., Newmeyer, D.D., Bax activation initiates the assembly of a multimeric catalyst that facilitates Bax pore formation in mitochondrial outer membranes. PLoS Biol., 10, 2012, e1001394.
167. Bordt, E.A., Clerc, P., Roelofs, B.A., Saladino, A.J., Tretter, L.s., Adam-Vizi, V., et al. The putative Drp1 inhibitor mdivi-1 is a reversible mitochondrial complex I inhibitor that modulates reactive oxygen species. Dev. Cell, 40, 2017 583.e6–594.e6.
168. Qi, X., Qvit, N., Su, Y.-C., Mochly-Rosen, D., A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 126 (2013), 789–802.
169. Wang, D., Wang, J., Bonamy, G., Meeusen, S., Brusch, R.G., Turk, C., et al. A small molecule promotes mitochondrial fusion in mammalian cells. Angew. Chem. Int. Ed. 51 (2012), 9302–9305.
170. Blankenstein, T., Coulie, P.G., Gilboa, E., Jaffee, E.M., The determinants of tumour immunogenicity. Nat. Rev. Cancer 12 (2012), 307–313.
171. Aymeric, L., Apetoh, L., Ghiringhelli, F.o., Tesniere, A., Martins, I., Kroemer, G., et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 70 (2010), 855–858.
172. Fucikova, J., Moserova, I., Urbanova, L., Bezu, L., Kepp, O., Cremer, I., et al. Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer. Front. Immunol., 6, 2015.
173. Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., Kroemer, G., Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17 (2016), 97–111.
174. Guo, H., Callaway, J.B., Ting, J.P., Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21 (2015), 677–687.
175. Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J.r., A role for mitochondria in NLRP3 inflammasome activation. Nature 469 (2011), 221–225.
176. Won, J.-H., Park, S., Hong, S., Son, S., Yu, J.-W., Rotenone-induced impairment of mitochondrial electron transport chain confers a selective priming signal for NLRP3 inflammasome activation. J. Biol. Chem. 290 (2015), 27425–27437.
177. Iyer, S.S., He, Q., Janczy, J.R., Elliott, E.I., Zhong, Z., Olivier, A.K., et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39 (2013), 311–323.
178. Allen, I.C., Scull, M.A., Moore, C.B., Holl, E.K., McElvania-TeKippe, E., Taxman, D.J., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30 (2009), 556–565.
179. Dashdorj, A., Jyothi, K.R., Lim, S., Jo, A., Nguyen, M.N., Ha, J., et al. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines. BMC Med., 11, 2013, 178.
180. Juliana, C., Fernandes-Alnemri, T., Kang, S., Farias, A., Qin, F., Alnemri, E.S., Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 287 (2012), 36617–36622.
181. Ichinohe, T., Yamazaki, T., Koshiba, T., Yanagi, Y., Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 17963–17968.
182. Koshiba, T., Bashiruddin, N., Kawabata, S., Mitochondria and antiviral innate immunity. Int. J. Biochem. Mol. Biol. 2 (2011), 257–262.
183. Castanier, C., Garcin, D., Vazquez, A., Arnoult, D., Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep. 11 (2010), 133–138.
184. Park, S., Won, J.-H., Hwang, I., Hong, S., Lee, H.K., Yu, J.-W., Defective mitochondrial fission augments NLRP3 inflammasome activation. Sci. Rep., 5, 2015, 15489.
185. Liu, P., Xie, Q., Wei, T., Chen, Y., Chen, H., Shen, W., Activation of the NLRP3 inflammasome induces vascular dysfunction in obese OLETF rats. Biochem. Biophys. Res. Commun. 468 (2015), 319–325.
186. Wang, X., Jiang, W., Yan, Y., Gong, T., Han, J., Tian, Z., et al. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat. Immunol. 15 (2014), 1126–1133.
187. Park, J., Choi, H., Min, J.S., Park, S.J., Kim, J.H., Park, H.J., et al. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J. Neurochem. 127 (2013), 221–232.
188. Kang, Y.J., Bang, B.-R., Han, K.H., Hong, L., Shim, E.-J., Ma, J., et al. Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling. Nat. Commun., 6, 2015.
189. Park, J., Choi, H., Min, J.S., Park, S.J., Kim, J.H., Park, H.J., et al. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J. Neurochem. 127 (2013), 221–232.
190. Waldhauer, I., Steinle, A., NK cells and cancer immunosurveillance. Oncogene 27 (2008), 5932–5943.
191. Cerwenka, A., Lanier, L.L., Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol. 16 (2016), 112–123.
192. O'Sullivan, T.E., Johnson, L.R., Kang, H.H., Sun, J.C., BNIP3-and BNIP3L-mediated mitophagy promotes the generation of natural killer cell memory. Immunity 43 (2015), 331–342.
193. Abarca-Rojano, E., Muniz-Hernàndez, S., Moreno-Altamirano, M.M.B., Mondragòn-Flores, R., Enriquez-Rincòn, F., Sànchez-Garcìa, F.J., Re-organization of mitochondria at the NK cell immune synapse. Immunol. Lett. 122 (2009), 18–25.
194. Lee, N., Zakka, L.R., Mihm, M.C., Schatton, T., Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy. Pathology 48 (2016), 177–187.
195. Noble, F., Mellows, T., Matthews, L.H.M., Bateman, A.C., Harris, S., Underwood, T.J., et al. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. Cancer Immunol. Immunother., 2016, 1–12.
196. Wu, R., Forget, M.-A., Chacon, J., Bernatchez, C., Haymaker, C., Chen, J.Q., et al. Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Cancer J. (Sudbury, Mass), 18, 2012, 160.
197. Schwindling, C., Quintana, A., Krause, E., Hoth, M., Mitochondria positioning controls local calcium influx in T cells. J. Immunol. 184 (2010), 184–190.
198. Quintana, A., Schwindling, C., Wenning, A.S., Becherer, U., Rettig, J., Schwarz, E.C., et al. T cell activation requires mitochondrial translocation to the immunological synapse. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 14418–14423.
199. Quintana, A., Pasche, M., Junker, C., Al-Ansary, D., Rieger, H., Kummerow, C., et al. Calcium microdomains at the immunological synapse: how ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation. EMBO J. 30 (2011), 3895–3912.
200. Roth, D., Krammer, P.H., Gulow, K., Dynamin related protein 1-dependent mitochondrial fission regulates oxidative signalling in T cells. FEBS Lett. 588:9 (2014), 1749–1754.
201. Buck, M.D., O'Sullivan, D., Pearce, E.L., T cell metabolism drives immunity. J. Exp. Med. 212:9 (2015), 1345–1360.
202. Buck, M.D., O'Sullivan, D., Geltink, R.I.K., Curtis, J.D., Chang, C.-H., Sanin, D.E., et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166:1 (2016), 63–76.
203. Pearce, E.L., Poffenberger, M.C., Chang, C.-H., Jones, R.G., Fueling immunity: insights into metabolism and lymphocyte function. Science, 342, 2013, 1242454.
204. van der Windt, G.J., Everts, B., Chang, C.-H., Curtis, J.D., Freitas, T.C., Amiel, E., et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36 (2012), 68–78.
205. Jacobelli, J., Matthews, M.E., Chen, S., Krummel, M.F., Activated T cell trans-endothelial migration relies on myosin-IIA contractility for squeezing the cell nucleus through endothelial cell barriers. PLoS One, 8, 2013, e75151.
206. Jiang, Y., Li, Y., Zhu, B., T-cell exhaustion in the tumor microenvironment. Cell. Death. Dis., 6(6), 2015, e1792.
207. Scharping, N.E., Menk, A.V., Moreci, R.S., Whetstone, R.D., Dadey, R.E., Watkins, S.C., et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45 (2016), 374–388.
208. Chang, C.-H., Qiu, J., O'Sullivan, D., Buck, M.D., Noguchi, T., Curtis, J.D., et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162 (2015), 1229–1241.
209. Liesa, M., Shirihai, O.S., Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17:4 (2013), 491–506.
210. Geiger, R., Rieckmann, J.C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167 (2016), 829e.13–842.e13.
211. Fisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., et al. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8T cells in chronic hepatitis B. Nat. Med. 23 (2017), 327–336.
212. Pauken, K.E., Wherry, E.J., Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36:4 (2015), 265–276.
213. Corrado, M., Mariotti, F.R., Trapani, L., Taraborrelli, L., Nazio, F., Cianfanelli, V., et al. Macroautophagy inhibition maintains fragmented mitochondria to foster T cell receptor-dependent apoptosis. EMBO J., 2016, e201593727.
214. Maher, S., Toomey, D., Condron, C., Bouchier-Hayes, D., Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol. Cell Biol. 80 (2002), 131–137.
215. Tabbekh, M., Franciszkiewicz, K., Haouas, H., Lécluse, Y., Benihoud, K., Raman, C., et al. Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice. J. Immunol. 187 (2011), 102–109.
216. Coussens, L.M., Werb, Z., Inflammation and cancer. Nature 420 (2002), 860–867.
217. Schoppmann, S.F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161 (2002), 947–956.
218. Zinselmeyer, B.H., Heydari, S., Sacristàn, C., Nayak, D., Cammer, M., Herz, J., et al. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J. Exp. Med. 210 (2013), 757–774.